C. Alvarado

发表

Randomized, active-controlled study of denosumab (AMG 162) in breast cancer patients with bone metastases not previously treated with intravenous (IV) bisphosphonates (BP).

G. Steger, K. Tonkin, A. Lipton, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chapter 86. Radiotherapy of Skeletal Metastases

P. Gascón, G. Steger, R. Berardi, 2008 .

Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases.

P. Gascón, G. Steger, J. Body, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extended Efficacy and Safety of Denosumab in Breast Cancer Patients with Bone Metastases Not Receiving Prior Bisphosphonate Therapy

P. Gascón, G. Steger, J. Body, 2008, Clinical Cancer Research.